Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Romero

Showing results (1-10 of 310) with videos related to

Pageof 31
Sort By:
Nature Reviews. Clinical Oncology|January 6, 2026
Base-edited CAR7 T cells are safe and efficacious in R/R T-ALLDiana Romero
Nature Reviews. Clinical Oncology|November 28, 2024
Benefit with glofitamab plus chemotherapy in transplant-ineligible R/R DLBCLDiana Romero
Nature Reviews. Clinical Oncology|February 20, 2025
Zenocutuzumab shows efficacy in NRG1 fusion-positive solid tumoursDiana Romero
Nature Reviews. Clinical Oncology|October 17, 2022
Benefit with neoadjuvant pembrolizumabDiana Romero
Nature Reviews. Clinical Oncology|May 25, 2016
Haematological cancer: TOURMALINE - new gem unearthed in the MM treatment landscapeDiana Romero
Nature Reviews. Clinical Oncology|August 12, 2015
Haematological cancer: promising results of BCL2 inhibitionDiana Romero
Nature Reviews. Clinical Oncology|February 3, 2016
Genetics: Divergence shapes recurrenceDiana Romero
Nature Reviews. Clinical Oncology|May 21, 2016
Gynaecological cancer: Chemoresistance - a little help from friendsDiana Romero
Nature Reviews. Clinical Oncology|April 14, 2016
Immunotherapy: Dressed to ImPRESsDiana Romero
Nature Reviews. Clinical Oncology|March 16, 2016
Immunotherapy: PD-1 says goodbye, TIM-3 says helloDiana Romero
Pageof 31

Showing results (1-10 of 310) with videos related to

Sort By:
Pageof 31
Nature Reviews. Clinical Oncology|January 6, 2026
Base-edited CAR7 T cells are safe and efficacious in R/R T-ALLDiana Romero
Nature Reviews. Clinical Oncology|November 28, 2024
Benefit with glofitamab plus chemotherapy in transplant-ineligible R/R DLBCLDiana Romero
Nature Reviews. Clinical Oncology|February 20, 2025
Zenocutuzumab shows efficacy in NRG1 fusion-positive solid tumoursDiana Romero
Nature Reviews. Clinical Oncology|October 17, 2022
Benefit with neoadjuvant pembrolizumabDiana Romero
Nature Reviews. Clinical Oncology|May 25, 2016
Haematological cancer: TOURMALINE - new gem unearthed in the MM treatment landscapeDiana Romero
Nature Reviews. Clinical Oncology|August 12, 2015
Haematological cancer: promising results of BCL2 inhibitionDiana Romero
Nature Reviews. Clinical Oncology|February 3, 2016
Genetics: Divergence shapes recurrenceDiana Romero
Nature Reviews. Clinical Oncology|May 21, 2016
Gynaecological cancer: Chemoresistance - a little help from friendsDiana Romero
Nature Reviews. Clinical Oncology|April 14, 2016
Immunotherapy: Dressed to ImPRESsDiana Romero
Nature Reviews. Clinical Oncology|March 16, 2016
Immunotherapy: PD-1 says goodbye, TIM-3 says helloDiana Romero
Pageof 31